The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets (Q73574723)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 February 2000

Language	Label	Description	Also known as
English	The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets	scientific article published on 01 February 2000

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

F D Tattersall

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

W Rycroft

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Cumberbatch

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

G Mason

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Tye

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D J Williamson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J J Hale

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S G Mills

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P E Finke

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M MacCoss

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Sadowski

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E Ber

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Cascieri

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R G Hill

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D E MacIntyre

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R J Hargreaves

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 February 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

number of pages

12

1 reference

based on heuristic

inferred from page(s)

Neuropharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

39

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

652-663

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

The pharmacology of the emetic response to upper gastrointestinal tract stimulation in Suncus murinus

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The tachykinin NK1 receptor antagonist GR205171 abolishes the retching activity of neurons comprising the central pattern generator for vomiting in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The site of the anti-emetic action of tachykinin NK1 receptor antagonists may exist in the medullary area adjacent to the semicompact part of the nucleus ambiguus.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Potent inhibition of both the acute and delayed emetic responses to cisplatin in piglets treated with GR205171, a novel highly selective tachykinin NK1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Dexamethasone can potentiate the anti-emetic action of a 5HT3 receptor antagonist on cyclophosphamide induced vomiting in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The effect of CP-99994 on the responses to provocative motion in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Skeletal muscle afferent fibres release substance P in the nucleus tractus solitarii of anaesthetized cats.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Effects of 5-HT3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The interaction of dexamethasone with ondansetron on drug-induced emesis in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Characterization of the binding of [125I-iodo-histidyl, methyl-Phe7] neurokinin B to the neurokinin-3 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Drug treatment of chemotherapy-induced delayed emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Initial high anti-emetic efficacy of granisetron with dexamethasone is not maintained over repeated cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900172-0

7 January 2021

Identifiers

10.1016/S0028-3908(99)00172-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10728886%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73574723&oldid=1786248824"